175 related articles for article (PubMed ID: 12457881)
21. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
Guilherme P; Fernandes I; Barbaro KC
Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
[TBL] [Abstract][Full Text] [Related]
22. Compared chemical properties of dermonecrotic and lethal toxins from spiders of the genus Loxosceles (Araneae).
Barbaro KC; Sousa MV; Morhy L; Eickstedt VR; Mota I
J Protein Chem; 1996 May; 15(4):337-43. PubMed ID: 8819009
[TBL] [Abstract][Full Text] [Related]
23. Purification and characterization of loxnecrogin, a dermonecrotic toxin from Loxosceles gaucho brown spider venom.
Cunha RB; Barbaro KC; Muramatsu D; Portaro FC; Fontes W; de Sousa MV
J Protein Chem; 2003 Feb; 22(2):135-46. PubMed ID: 12760418
[TBL] [Abstract][Full Text] [Related]
24. Description of a serpin toxin in Loxosceles (Brown spider) venoms: Cloning, expression in baculovirus-infected insect cells and functional characterization.
Schemczssen-Graeff Z; Justa HCD; Nowatzki J; Baldissera AB; Polli NLC; De-Bona E; Rossi IV; Ramirez MI; Minozzo JC; Matsubara FH; Senff-Ribeiro A; Gremski LH; Veiga SS
Int J Biol Macromol; 2021 Jul; 183():1607-1620. PubMed ID: 34029585
[TBL] [Abstract][Full Text] [Related]
25. Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom.
Mendes TM; Oliveira D; Figueiredo LF; Machado-de-Avila RA; Duarte CG; Dias-Lopes C; Guimarães G; Felicori L; Minozzo JC; Chávez-Olortegui C
Vaccine; 2013 Jun; 31(25):2749-55. PubMed ID: 23664158
[TBL] [Abstract][Full Text] [Related]
26. Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides.
de Moura J; Felicori L; Moreau V; Guimarães G; Dias-Lopes C; Molina L; Alvarenga LM; Fernandes P; Frézard F; Ribeiro RR; Fleury C; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
Vaccine; 2011 Oct; 29(45):7992-8001. PubMed ID: 21872636
[TBL] [Abstract][Full Text] [Related]
27. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA).
Lee S; Lynch KR
Biochem J; 2005 Oct; 391(Pt 2):317-23. PubMed ID: 15926888
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
29. Cloning, expression and characterization of a phospholipase D from Loxosceles gaucho venom gland.
Magalhães GS; Caporrino MC; Della-Casa MS; Kimura LF; Prezotto-Neto JP; Fukuda DA; Portes-Junior JA; Neves-Ferreira AG; Santoro ML; Barbaro KC
Biochimie; 2013 Sep; 95(9):1773-83. PubMed ID: 23770445
[TBL] [Abstract][Full Text] [Related]
30. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
[TBL] [Abstract][Full Text] [Related]
31. Brown spiders and loxoscelism.
da Silva PH; da Silveira RB; Appel MH; Mangili OC; Gremski W; Veiga SS
Toxicon; 2004 Dec; 44(7):693-709. PubMed ID: 15500846
[TBL] [Abstract][Full Text] [Related]
32. A novel expression profile of the Loxosceles intermedia spider venomous gland revealed by transcriptome analysis.
Gremski LH; da Silveira RB; Chaim OM; Probst CM; Ferrer VP; Nowatzki J; Weinschutz HC; Madeira HM; Gremski W; Nader HB; Senff-Ribeiro A; Veiga SS
Mol Biosyst; 2010 Dec; 6(12):2403-16. PubMed ID: 20644878
[TBL] [Abstract][Full Text] [Related]
33. Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders.
Souza NA; Dias-Lopes C; Matoso ÍHG; de Oliveira CFB; Chávez-Olortegui CD; Minozzo JC; Felicori LF
Vaccine; 2018 Nov; 36(48):7324-7330. PubMed ID: 30352745
[TBL] [Abstract][Full Text] [Related]
34. Engineered antigen containing epitopes from Loxosceles spp. spider toxins induces a monoclonal antibody (Lox-mAb3) against astacin-like metalloproteases.
Costa TGF; Costal-Oliveira F; de Assis TCS; Lima SA; Martins CA; Finco AB; Veiga SS; Soccol VT; Machado-de-Ávila RA; Figueiredo LFM; Minozzo JC; Kalapothakis E; Guerra-Duarte C; Alvarenga LM; Chávez-Olórtegui C
Int J Biol Macromol; 2020 Nov; 162():490-500. PubMed ID: 32574737
[TBL] [Abstract][Full Text] [Related]
35. Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.
Karim-Silva S; Moura Jd; Noiray M; Minozzo JC; Aubrey N; Alvarenga LM; Billiald P
Immunol Lett; 2016 Aug; 176():90-6. PubMed ID: 27288291
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory events induced by brown spider venom and its recombinant dermonecrotic toxin: a pharmacological investigation.
Paludo KS; Biscaia SM; Chaim OM; Otuki MF; Naliwaiko K; Dombrowski PA; Franco CR; Veiga SS
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):323-33. PubMed ID: 19041422
[TBL] [Abstract][Full Text] [Related]
37. A novel hyaluronidase from brown spider (Loxosceles intermedia) venom (Dietrich's Hyaluronidase): from cloning to functional characterization.
Ferrer VP; de Mari TL; Gremski LH; Trevisan Silva D; da Silveira RB; Gremski W; Chaim OM; Senff-Ribeiro A; Nader HB; Veiga SS
PLoS Negl Trop Dis; 2013; 7(5):e2206. PubMed ID: 23658852
[TBL] [Abstract][Full Text] [Related]
38. Biotechnological applications of brown spider (Loxosceles genus) venom toxins.
Senff-Ribeiro A; Henrique da Silva P; Chaim OM; Gremski LH; Paludo KS; Bertoni da Silveira R; Gremski W; Mangili OC; Veiga SS
Biotechnol Adv; 2008; 26(3):210-8. PubMed ID: 18207690
[TBL] [Abstract][Full Text] [Related]
39. Isolation and identification of Clostridium perfringens in the venom and fangs of Loxosceles intermedia (brown spider): enhancement of the dermonecrotic lesion in loxoscelism.
Monteiro CL; Rubel R; Cogo LL; Mangili OC; Gremski W; Veiga SS
Toxicon; 2002 Apr; 40(4):409-18. PubMed ID: 11738234
[TBL] [Abstract][Full Text] [Related]
40. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
